Defense verdict comes as GSK faces several additional Zantac trials in Florida, Pennsylvania and Nevada in the coming months, each raising similar allegations that the recalled heartburn drug caused cancer to develop in former users.
Verdict comes in a Zantac lawsuit against GlaxoSmithKline and Boehringer Ingelheim, weeks after Sanofi and Pfizer announced agreements to settle thousands of Zantac cancer claims.
Jury is hearing evidence after several prior Zantac cancer lawsuits were settled weeks before trial was set to begin in other courts.
Elderly patients who undergo colonoscopies are unlikely to choose treatment if colorectal cancer cells are detected, say researchers.
Bendectin contains dicyclomine, an active ingredient used in the anti-nausea drug thalidomide, which was linked to severe birth defects.
Side effects of the diet pill led to a recall in 2020. However, new lawsuits continue to be filed over cancer caused by Belviq.
